Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
Clinical trial NCT04490915 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04490915
- Sponsor
- Neurocrine Biosciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2023-07-19
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.